{"id":118659,"date":"2017-01-03T09:29:41","date_gmt":"2017-01-03T14:29:41","guid":{"rendered":"https:\/\/today.uconn.edu\/?p=118659"},"modified":"2023-02-23T15:30:21","modified_gmt":"2023-02-23T20:30:21","slug":"heart-in-a-dish-sheds-light-on-genetics-heart-disease","status":"publish","type":"post","link":"https:\/\/today.uconn.edu\/2017\/01\/heart-in-a-dish-sheds-light-on-genetics-heart-disease\/","title":{"rendered":"&#8216;Heart-In-A-Dish&#8217; Sheds Light on Genetics of Heart Disease"},"content":{"rendered":"<p>When a patient shows symptoms of cancer, a biopsy is taken. Scientists study the tissue, examining it under a microscope to determine exactly what\u2019s going on.<\/p>\n<p>But the same can\u2019t be done for heart disease, the leading cause of death among Americans. Not until now.<\/p>\n<figure id=\"attachment_118680\" aria-describedby=\"caption-attachment-118680\" style=\"width: 600px\" class=\"wp-caption alignleft\"><a href=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a041.jpg\"><img decoding=\"async\" class=\"wp-image-118680 img-responsive lazyload\" data-src=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a041-1024x683.jpg\" alt=\"Dr. J. Travis Hinson holds petri dishes containing heart cells. Hinson, a joint faculty appointment at UConn Health and The Jackson Laboratory for Genomic Medicine, has pioneered a system to study the genetics of heart failure by recreating beating heart tissue using patients' stem cells. (Peter Morenus\/UConn Photo)\" width=\"600\" height=\"400\" data-srcset=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a041-1024x683.jpg 1024w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a041-300x200.jpg 300w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a041-768x512.jpg 768w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a041-630x420.jpg 630w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a041-150x100.jpg 150w\" data-sizes=\"(max-width: 600px) 100vw, 600px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 600px; --smush-placeholder-aspect-ratio: 600\/400;\" \/><\/a><figcaption id=\"caption-attachment-118680\" class=\"wp-caption-text\">Dr. J. Travis Hinson holds petri dishes containing heart cells. Hinson, a joint faculty appointment at UConn Health and The Jackson Laboratory for Genomic Medicine, has pioneered a system to study the genetics of heart failure by recreating beating heart tissue using patients&#8217; stem cells. (Peter Morenus\/UConn Photo)<\/figcaption><\/figure>\n<p><a href=\"http:\/\/facultydirectory.uchc.edu\/profile?profileId=Hinson-John\">Dr. J. Travis Hinson<\/a>, a physician-scientist who joined the faculties of UConn Health and The Jackson Laboratory for Genomic Medicine (<a href=\"http:\/\/www.jax.org\">JAX<\/a>) in 2016, is using a novel system he pioneered to study heart tissue.<\/p>\n<p>Hinson engineers heart-like structures with cells containing specific genetic mutations in order to study the genetics of cardiomyopathies, diseases of the heart muscle that can lead to heart failure and, ultimately, death.<\/p>\n<p>\u201cWe basically try to rebuild a little piece of a patient\u2019s heart in a dish,\u201d says Hinson, who developed the technique during a postdoctoral fellowship at Brigham &amp; Women&#8217;s Hospital.<\/p>\n<p>He combines cardiac muscle cells with support cells, such as fibroblasts, and other key factors, including extracellular matrix proteins. Although these tiny, three-dimensional structures do not pump blood, they do contract rhythmically, and their beating strength can be studied.<\/p>\n<p><strong>Making a Difference<\/strong><br \/>\nHinson is applauded for his ability to move seamlessly between research, clinical practice, and teaching \u2013 the three prongs of an academic medical center\u2019s mission. He\u2019s able to do so, perhaps, because his own career began at the intersection of multiple scientific specialties.<\/p>\n<p>As an undergraduate at the University of Pennsylvania, Hinson interned at DuPont in New Jersey to explore his interests in chemistry and engineering. But he soon realized that his passion for science needed a real-word focus. \u201cI wanted to do science that made a difference in people\u2019s health,\u201d he says.<\/p>\n<p>The same summer, he volunteered in the emergency department of a local hospital. Impressed by a cardiologist\u2019s calm and collected manner in a crisis, and gaining interest in the heart, Hinson changed his career trajectory from engineering to medical school.<\/p>\n<p>Hinson joined the laboratory of Dr. Robert J. Levy, a pediatric cardiologist and researcher at The Children\u2019s Hospital of Philadelphia, working to harness gene therapy techniques to make artificial heart valves and other cardiovascular devices more durable. Through this early foray into biomedical research, Hinson deepened his interest in biomedical science and gained an appreciation of the work of a physician-scientist.<\/p>\n<p>While doing research in Dr. Christine Seidman\u2019s lab as part of his MD at Harvard Medical School, he chose to lead a project on Bj\u00f6rnstad syndrome, a rare, inherited syndrome characterized by hearing loss and twisted, brittle hair. At the time, little was known about the molecular causes of the disorder, although the genetic culprits were thought to reside within a large swath of chromosome 2. Using genetic mapping techniques and DNA sequencing, Hinson homed in on the precise mutations.<\/p>\n<p>In addition to casting light on disease biology, he glimpsed the power of genomic information. \u201cI was fascinated by the potential for understanding new genes that cause human diseases,&#8221; Hinson says, &#8220;and how important that was to society.\u201d<\/p>\n<p><strong>Matters of the Heart<\/strong><br \/>\nThroughout his medical training, Hinson noticed there were some significant stumbling blocks to gathering a deep knowledge of heart disease, particularly cardiomyopathies.<\/p>\n<figure id=\"attachment_118679\" aria-describedby=\"caption-attachment-118679\" style=\"width: 500px\" class=\"wp-caption alignleft\"><a href=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a009.jpg\"><img decoding=\"async\" class=\"wp-image-118679 img-responsive lazyload\" data-src=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a009.jpg\" alt=\"Dr. J. Travis Hinson leads a tour of his lab. (Peter Morenus\/UConn Photo)\" width=\"500\" height=\"333\" data-srcset=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a009.jpg 3000w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a009-300x200.jpg 300w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a009-768x512.jpg 768w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a009-1024x683.jpg 1024w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a009-630x420.jpg 630w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Tour160315a009-150x100.jpg 150w\" data-sizes=\"(max-width: 500px) 100vw, 500px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 500px; --smush-placeholder-aspect-ratio: 500\/333;\" \/><\/a><figcaption id=\"caption-attachment-118679\" class=\"wp-caption-text\">Dr. J. Travis Hinson leads a tour of his lab. (Peter Morenus\/UConn Photo)<\/figcaption><\/figure>\n<p>Cardiac muscle has essentially two paths toward dysfunction and ultimate failure. It can either dilate\u00a0\u2013 become abnormally large and distended \u2013 or it can thicken. Both routes severely impair how well the heart performs as a pump. These conditions, known as dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), can stem from pre-existing disorders of the heart, such as a previous heart attack or long-standing hypertension, or from DNA mutations.<\/p>\n<p>Thanks to advances in genomics over the last two decades, more than 40 genes have been identified that underlie cardiomyopathy. But unlike diseases such as cystic fibrosis or sickle cell anemia, where it is fairly common for affected individuals from different families to carry the exact same genetic typo, it is exceedingly rare for unrelated patients with cardiomyopathy to share the same mutation. With such a complex genetic architecture, figuring out how the different genes and gene mutations contribute to heart disease has been an enormous challenge.<\/p>\n<p>Because of this formidable hurdle, drug discovery for the cardiomyopathies has languished. \u201cThere really has not been a paradigm-shifting drug developed for heart failure in the last 20 years,\u201d says Hinson. Moreover, the few treatments that do exist are primarily aimed at controlling patients\u2019 symptoms, not slowing or halting their disease.<\/p>\n<p>Hinson aims to improve this picture. With his \u201cheart-in-a-dish\u201d technique, he and his team are now unraveling the effects of genetic mutations on cardiac biology.<\/p>\n<blockquote>\n  <p>We basically try to rebuild a little piece of a patient\u2019s heart in a dish. <cite> &#8212 Dr. J. Travis Hinson<\/cite><\/p>\n<\/blockquote>\n<p>The system harnesses multiple recent advances in both stem cell and genome editing technologies. With these capabilities, Hinson and his colleagues can isolate skin or blood cells directly from cardiomyopathy patients and coax them to form heart muscle cells, making it possible to study the biological effects of patients\u2019 own mutations. Moreover, he can correct those mutations, or create additional ones, to further probe how genetic differences influence heart biology.<\/p>\n<p>Part of the allure of Hinson\u2019s approach is that it can be readily applied to studying other forms of heart disease. It can also be leveraged for drug discovery, providing a platform to screen and test compounds with therapeutic potential in a wide range of cardiovascular diseases.<\/p>\n<p>In addition to his research lab based at JAX Genomic Medicine, Hinson continues to practice cardiology at UConn Health. He helps run a specialized clinic focused on genetic forms of heart disease, as well as arrhythmias, connective tissue disorders, and other conditions.<\/p>\n<p>\u201cWe have an exciting opportunity to provide clinical services in cardiac genetics in the corridor between New York and Boston,\u201d he says. That means state-of-the-art genetic testing, including gene panels and genome sequencing, as well as genetic counseling for both patients and family members to help inform disease diagnosis and guide treatment. Although there are only a handful of treatments now available, Hinson believes this clinic will be uniquely poised to take advantage of a new generation of personalized treatments that are precisely tailored to patients\u2019 specific gene mutations.<\/p>\n<p>\u201cTravis really is a quintessential physician-scientist,\u201d says Dr. Bruce Liang, dean of UConn School of Medicine and director of the Pat and Jim Calhoun Cardiology Center at UConn Health.<\/p>\n<p>\u201cHe has a remarkable ability to link basic science with important clinical problems, and his work holds a great deal of promise for developing new treatments for patients with cardiomyopathy. I wish there were two or three Travis Hinsons.\u201d<\/p>\n<aside class=\"grey-sidebar full-sidebar\">\n  <\/p>\n<h3>New Medication, Moving into Clinical Trial, May Reverse Heart Failure<\/h3>\n<p><figure id=\"attachment_118678\" aria-describedby=\"caption-attachment-118678\" style=\"width: 292px\" class=\"wp-caption alignleft\"><a href=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339.jpg\"><img decoding=\"async\" class=\"wp-image-118678 size-medium img-responsive lazyload\" data-src=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339-292x300.jpg\" alt=\"Dr. Bruce Liang. (Janine Gelineau\/UConn Health Photo)\" width=\"292\" height=\"300\" data-srcset=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339-292x300.jpg 292w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339-768x790.jpg 768w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339-995x1024.jpg 995w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339-408x420.jpg 408w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339-32x32.jpg 32w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339-50x50.jpg 50w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2016\/10\/Liang_Bruce_JGelineau1339.jpg 1944w\" data-sizes=\"(max-width: 292px) 100vw, 292px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 292px; --smush-placeholder-aspect-ratio: 292\/300;\" \/><\/a><figcaption id=\"caption-attachment-118678\" class=\"wp-caption-text\">Dr. Bruce Liang. (Janine Gelineau\/UConn Health Photo)<\/figcaption><\/figure><\/p>\n<p><strong>Dr. Bruce T. Liang<\/strong> and colleagues at UConn Health, in collaboration with the National Institutes of Health (NIH), are currently testing a medication to treat heart failure, which currently affects 6 million Americans and is projected to triple in prevalence by 2030, as more heart attack patients survive.<\/p>\n<p>Liang and his research team are investigating the power of the molecule methanocarba derivative of 2-Cl-AMP and its cardioprotective effects against heart failure. The debilitating and ultimately fatal condition can stem from a heart attack, virus, long-standing high blood pressure, or genetics.<\/p>\n<p>While heart failure can be managed with medication, diet restrictions, and lifestyle modification, severe cases lead to patients needing a risky heart transplant or a ventricular assist device (VAD).<\/p>\n<p>And according to Liang, these limited treatment options are costly and may have complications. Further, not everyone is a candidate for the procedures.<\/p>\n<p>Those advanced heart failure patients ineligible for a transplant or VAD are left with an intravenous medication called positive inotropes, which helps strengthen the contraction of their heart muscle to keep their heart beating. While this results in short-term improvement, the overall heart function declines rapidly.<\/p>\n<p>In 2011, Liang formed a startup based on his research, Cornovus Pharmaceuticals Inc., to develop potential treatments for these advanced heart failure patients. The name comes from the Latin \u201ccor,\u201d for heart, and \u201cnovus,\u201d meaning new.<\/p>\n<p>So far, in animal models, the methanocarba treatment has been shown to improve the failing heart muscle\u2019s performance and even reverse the condition. Liang and his team hope their innovative solution will show the same promise in human clinical trials.<\/p>\n<p>With patents in both the United States and the European Union, the team hopes to conduct the first-in-human tests in the U.S. in the near future, following approval by the FDA.<\/p>\n<p>Liang and his team recently received an award from the NIH\u2019s SMARTT (Science Moving towArds Research Translation and Therapy) program, and have received further funding from Connecticut Innovation and private support from Carole and Ray Neag to move into first-in-human testing.<\/p>\n<p>\u201cThere is a pressing need to find new treatment for these patients,\u201d says Liang. \u201cI look forward, with much anticipation, to a day in the not-too-distant future when I can say to a patient with advanced heart failure that they will get better.\u201d<\/aside>\n<p><em>This article was first published in <a href=\"http:\/\/healthjournal.uconn.edu\/2016\/10\/12\/tell-tale-heart\/\">UConn Health Journal<\/a>.<\/em><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Advances in research on the human heart put UConn Health on the cutting edge.<\/p>\n","protected":false},"author":98,"featured_media":119013,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","wds_primary_category":0,"wds_primary_series":0,"wds_primary_attribution":0,"footnotes":""},"categories":[1969,2231,2076,1868,179],"tags":[],"magazine-issues":[],"coauthors":[1873],"class_list":["post-118659","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiology","category-health-well-being","category-research","category-meds","category-uconn-health","series-heart-health"],"pp_statuses_selecting_workflow":false,"pp_workflow_action":"current","pp_status_selection":"publish","acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-29 05:32:22","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/118659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/users\/98"}],"replies":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/comments?post=118659"}],"version-history":[{"count":13,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/118659\/revisions"}],"predecessor-version":[{"id":120739,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/118659\/revisions\/120739"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/media\/119013"}],"wp:attachment":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/media?parent=118659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/categories?post=118659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/tags?post=118659"},{"taxonomy":"magazine-issue","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/magazine-issues?post=118659"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/coauthors?post=118659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}